Roger Adsett

Roger Adsett

Directeur des opérations chez INSMED INCORPORATED

Fortune : 10 M $ au 30/06/2024

55 ans
100 relations
Health Technology
Consumer Services
Finance

Postes actifs de Roger Adsett

SociétésPosteDébutFin
INSMED INCORPORATED Directeur des opérations 14/11/2019 -
Corporate Officer/Principal 27/09/2016 14/11/2019

Historique de carrière de Roger Adsett

Anciens postes connus de Roger Adsett

SociétésPosteDébutFin
LANDOS BIOPHARMA, INC. Directeur/Membre du Conseil 08/03/2022 23/05/2024
Independent Dir/Board Member 08/03/2022 23/05/2024
SHIRE Corporate Officer/Principal 01/10/2005 01/09/2016
ASTRAZENECA PLC Sales & Marketing 01/11/1994 01/10/2005
Nexium, Inc. Sales & Marketing - -
AstraZeneca R & D Lund Sales & Marketing - -

Formation de Roger Adsett

The Wharton School of the University of Pennsylvania Masters Business Admin
Bucknell University Undergraduate Degree

Statistiques

Internationale

Etats-Unis 6
Irlande 2
Suède 2

Opérationnelle

Sales & Marketing 3
Corporate Officer/Principal 2
Chief Operating Officer 1

Sectorielle

Health Technology 5
Consumer Services 3
Finance 2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Sociétés cotées3
INSMED INCORPORATED

Health Technology

ASTRAZENECA PLC

Health Technology

LANDOS BIOPHARMA, INC.

Health Technology

Entreprise privées3
Shire Plc
Logo Shire Plc

Shire Plc

Pharmaceuticals: MajorHealth Technology

Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland.

Health Technology

AstraZeneca R & D Lund

Nexium, Inc.

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Roger Adsett
  4. Expérience